Arix Bioscience boost after Harpoon NASDAQ float
The fair value of the company's investment in Harpoon has grown by £6.2mln
Company
Arix Bioscience PLC
LON:ARIX
Arix Bioscience is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. The company collaborates with exceptional entrepreneurs and provide the capital, expertise and global networks needed to help accelerate their ideas into important new treatments for patients. As a listed company, it aims to bring this growth phase of the industry to a broader range of investors.
180 stories · page 6 of 9
Investments and investor services
FTSE 100 joins the decline in global equities to close lower
There is not a lot of earnings news on either side of the Atlantic to drive markets higher
Arix Bioscience says Harpoon Therapeutics’ IPO pricing range would hike holding value by £4.2mln-£7.9mln
The global healthcare and life science company supporting medical innovation said that increase was compared to the current £20.2mln value of its holding in Harpoon
Archive
Proactive news snapshot: Shield Therapeutics, ANGLE, Westminster Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Proactive news snapshot: Sure Ventures, Arix Bioscience, Providence Resources
A glance at some of the day's highlights from the Proactive Investors newswire
Arix Bioscience portfolio firm Harpoon Therapeutics plans US IPO
Harpoon Therapeutics has filed a registration statement with the US Securities and Exchange Commission relating to a proposed underwritten initial public offering
Investments and investor services
Edenville Energy falls as it notifies shareholders of plans to switch Nomad
A look at the day's major movers, including RM, MySale, Bilby, MC Mining and Bango
Archive
Proactive news snapshot: Eurasia Mining, Bango, Telit Communications …
A glance at some of the day's highlights from the Proactive Investors newswire
Arix Bioscience sees multiple advancements across portfolio
Since September, the group's portfolio has steamed ahead with a number of new and successful clinical trials, as well as a boost from the float of one of its companies on the Nasdaq
Archive
Proactive news snapshot: Faron Pharmaceuticals, Diversified Gas & Oil, Mkango Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Interserve weak as Kier Group cash call comments spark concerns for constructors
A look at some of the London market's biggest risers and fallers on Monday
Arix Bioscience’s portfolio firm Autolus doses first patient in clinical trial of AUTO4 T-cell lymphoma therapy
PTCL is a form of cancer that arises in areas of the body such as lymph nodes, spleen, the gastrointestinal tract, and skin
FTSE 100 clings on to triple-digit gain
The Footsie looked destined to finish well off the top but still sporting a handsome gain following a weekend of deals at the G20 and Opec meetings
Investments and investor services
BigDish beefs up on bid interest but is still below its flotation price
A look at day's gliders and sliders, including Integumen, MC Mining, Intermediate Capital, Bovis Homes and other house-builders, Dart Group,Flybe, easyJet, IAG, Learning Technologies and Oilex.
Archive
Proactive news snapshot: VR Education, Bigdish, Learning Technologies …
A glance at some of the day's highlights from the Proactive Investors newswire
Arix Biosciences hails phase I success of investee company Pharmaxis
Arix is a cornerstone investor in the ASX life sciences group
Investments and investor services
FTSE 100 closes marginally higher as PM May defends draft Brexit deal
The UK's premier share index closed up around four points at 7,038, while the FTSE 250 shed almost 248 points at 18,662.
Archive
Proactive news snapshot: Sirius Minerals, MaxCyte, Arix Bioscience...
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Two Shields and Bushveld wave the flag for African mineral assets
A look at the day's winners and sinners, including Dignity, Online Blockchain, Restaurant Group, TomCo Energy, Johnston Press, GYG, Anglo African Agriculture and Carr's Group